大族激光(002008.SZ):研發的紫外皮秒激光器、紫外納秒激光器等產品已實現量產,主要集成在整機設備上統一銷售
格隆匯7月19日丨有投資者向大族激光(002008.SZ)提問,“最近媒體報道中科院研製成功新型晶體實現深紫外激光輸出,大族激光在深紫外激光方面有哪些研究,是否實現量產,應用在哪些方面。”
大族激光回覆稱,紫外激光器憑藉獨特的“冷加工”熱影響區極小的優勢,在高端製造領域的非金屬脆性材料中實現超精細加工和微結構製作,公司研發的紫外皮秒激光器、紫外納秒激光器等產品已實現量產,主要集成在整機設備上統一銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.